Skip Nav Destination
Issues
December 2017
ISSN 2296-5270
EISSN 2296-5262
In this Issue
Journal Name Change
Vol. 1-36 (1978-2013) were published under the journal's former title Onkologie.
Oncology Research and Treatment 2017, Vol. 40, No. 12
Editorial Board / Contents / Imprint
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 733–738.
https://doi.org/10.1159/000485484
Acknowledgement to Reviewers
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 741–743.
https://doi.org/10.1159/000485229
Editorial
Oncological Rehabilitation and Cancer Survivorship
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 744.
https://doi.org/10.1159/000485188
Review Article
Late Effects and Long-Term Follow-Up after Cancer in Childhood
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 746–750.
https://doi.org/10.1159/000484936
Family-Oriented Rehabilitation (FOR) and Rehabilitation of Adolescents and Young Adults (AYA) in Pediatric Oncology
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 752–758.
https://doi.org/10.1159/000484609
Return to Work of Cancer Survivors
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 760–763.
https://doi.org/10.1159/000485079
Rehabilitation of Cancer Survivors with Long-Term Toxicities
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 764–771.
https://doi.org/10.1159/000485187
Oncological Rehabilitation
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 772–777.
https://doi.org/10.1159/000481709
Original Article
Adjuvant Radiotherapy in High-Risk Squamous Cell Carcinoma of the Vulva: A Two-Institutional Italian Experience
Subject Area:
Oncology
Concetta Laliscia; Maria G. Fabrini; Ines Cafaro; Amelia Barcellini; Davide Baldaccini; Mario Miniati; Emanuela Parietti; Riccardo Morganti; Fabiola Paiar; Angiolo Gadducci
Oncol Res Treat (2017) 40 (12): 778–783.
https://doi.org/10.1159/000479876
Successful Evidence-Based Treatment of Patients with Advanced Pancreatic Cancer in Community-Based Oncology Group Practices
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 784–788.
https://doi.org/10.1159/000480016
The Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue Subscale): Validity and Reliability of the Iranian Version
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 789–793.
https://doi.org/10.1159/000479588
Society Bulletins
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 794–797.
https://doi.org/10.1159/000485364
PharmaForum
Carfilzomib. Überlebensvorteil beim multiplen Myelom in der Rezidivsituation
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 799.
https://doi.org/10.1159/000485479
Dasatinib bei chronischer myeloischer Leukämie. Retrospektive Analysen unterstreichen Vorteil gegenüber Imatinib
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 800–801.
https://doi.org/10.1159/000485480
Fortgeschrittene gastrointestinale Tumoren. Ramucirumab: Prognostische Vorteile für vorbehandelte Patienten
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 802–803.
https://doi.org/10.1159/000485481
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 805.
https://doi.org/10.1159/000485482
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 806–810.
https://doi.org/10.1159/000485483
Meetings and Conferences
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 812–814.
https://doi.org/10.1159/000485365
Contents Vol. 40, 2017
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (12): 816–820.
https://doi.org/10.1159/000485478
